| NOS2A |
NOS2A, NOS2: Nitric oxide synthase, inducible |
CYP4F8 |
CYP4F8: Cytochrome P450 4F8 |
0.265 |
Evidence |
|
| OXER1 |
OXER1, GPR170, TG1019: Oxoeicosanoid receptor 1 |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
0.265 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
GPR119 |
GPR119: Probable G-protein coupled receptor 119 |
0.265 |
Evidence |
|
| GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
GPR52 |
GPR52: Probable G-protein coupled receptor 52 |
0.265 |
Evidence |
|
| C6orf11 |
FP221, WDR46, BING4, C6orf11: WD repeat-containing protein 46 |
LARS |
LARS, KIAA1352: Leucyl-tRNA synthetase, cytoplasmic |
0.265 |
Evidence |
|
| TNFRSF18 |
TNFRSF18, AITR, UNQ319/PRO364, GITR: Tumor necrosis factor receptor superfamily |
TNFSF15 |
TNFSF15, RP11-428F18.1-001, hCG_27396: TNF superfamily ligand TL1A |
0.265 |
Evidence |
|
| GABRB3 |
GABRB3: Gamma-aminobutyric acid receptor subunit beta-3 precursor |
CHRND |
CHRND, ACHRD: Acetylcholine receptor subunit delta precursor |
0.265 |
Evidence |
|
| NEUROD2 |
NEUROD2, NDRF: Neurogenic differentiation factor 2 |
MNT |
MNT, ROX: Max-binding protein MNT |
0.265 |
Evidence |
|
| APOE |
APOE: Apolipoprotein E precursor |
BPIL2 |
BPIL2: Bactericidal/permeability-increasing protein-like 2 precursor |
0.265 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
OR12D3 |
OR12D3: Olfactory receptor 12D3 |
0.265 |
Evidence |
|
| MRGPRX3 |
MRGPRX3, MRGX3, SNSR1, SNSR2: Mas-related G-protein coupled receptor member X3 |
GNAI2 |
Galphai2 protein |
0.265 |
Evidence |
|
| TCF4 |
TCF4, ITF2, SEF2: Transcription factor 4 |
HES4 |
HES4: Transcription factor HES-4 |
0.265 |
Evidence |
|
| CACNA1B |
CACNA1B, CACH5, CACNL1A5: Voltage-dependent N-type calcium channel subunit alpha |
SCN10A |
SCN10A, PN3: Sodium channel protein type 10 subunit alpha |
0.265 |
Evidence |
|
| SLC19A2 |
SLC19A2, THT1, TRMA: Thiamine transporter 1 |
GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
0.265 |
Evidence |
|
| GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
GPR161 |
GPR161: Probable G-protein coupled receptor 161 |
0.265 |
Evidence |
|
| BHLHB8 |
BHLHB8, MIST1: Class B basic helix-loop-helix protein 8 |
OLIG1 |
OLIG1: Oligodendrocyte transcription factor 1 |
0.265 |
Evidence |
|
| F7 |
F7: Coagulation factor VII precursor |
SLC14A1 |
SLC14A1, HUT11, JK, RACH1, UT1, UTE: Urea transporter, erythrocyte |
0.265 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
PROKR1 |
PROKR1, GPR73, PKR1: Prokineticin receptor 1 |
0.265 |
Evidence |
|
| GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
OXGR1 |
OXGR1, GPR80, GPR99, P2RY15, P2Y15: 2-oxoglutarate receptor 1 |
0.265 |
Evidence |
|
| TNFSF12 |
TNFSF13, APRIL, UNQ383/PRO715, TALL2, ZTNF2: Tumor necrosis factor ligand superf |
EDA2R |
EDA2R, TNFRSF27, UNQ2448/PRO34080/PRO5727, XEDAR: Tumor necrosis factor receptor |
0.265 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
PROKR1 |
PROKR1, GPR73, PKR1: Prokineticin receptor 1 |
0.265 |
Evidence |
|
| ZSCAN1 |
ZSCAN1: Zinc finger and SCAN domain-containing protein 1 |
ZNF214 |
ZNF214, BAZ1: Zinc finger protein 214 |
0.265 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
FPRL2 |
FPRL2, FPRH1: FMLP-related receptor II |
0.265 |
Evidence |
|
| NALP12 |
NLRP12, NALP12, PYPAF7, RNO: NACHT, LRR and PYD domains-containing protein 12 |
TEP1 |
TEP1, TLP1, TP1: Telomerase protein component 1 |
0.265 |
Evidence |
|
| GPR31 |
GPR31: Probable G-protein coupled receptor 31 |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
0.265 |
Evidence |
|
- 
- 
-